Skip to main content

Posts

Showing posts with the label Thromboelastography

Sonoclot Thromboelastography India Cardiac Surgery Liver Transplant Platelet Function Analyzer TEG Titanium Cardiac Surgery Instruments

Andaman and Nicobar Islands union territory Port Blair Andhra Pradesh Hyderabad  Amaravati  Arunachal Pradesh Itanagar Assam Dispur Bihar Patna Chandigarh union territory Chandigarh Chhattisgarh Naya Raipur Dadra and Nagar Haveli union territory Silvassa Daman and Diu union territory Daman National Capital Territory of Delhi union territory New Delhi Goa Panaji Gujarat Gandhinagar Haryana Chandigarh Himachal Pradesh Shimla Dharamshala Jammu and Kashmir Srinagar  Jammu  Jharkhand Ranchi Karnataka Bengaluru Kerala Thiruvananth...

Problems with Thromboelastography TEG 5000 India

Problems with Thromboelastography TEG 5000 India TEG 5000 needs significant fibrin polymerization before the curve opens and will FAIL to give results as in this case.  After spending Rs. 12.0 lacs you face the same dilemma, what you face without TEG 5000 After transfusion, following is the TEG 5000 tracing and NO result after 27 minutes: www.lifediagnostica.com/sonoclot 

Sonoclot, Thromboelastography, Liver Transplant India, Cardiac Surgery, Cath Lab, www.lifediagnostica.com, ECMO, ACT Machine, Dialysis, Life Diagnostica

Sonoclot, Thromboelastography, Cardiac Surgery, ACT Machine India, Cath Lab, Liver Transplant India, www.lifediagnostica.com, Life Diagnostica

Sonoclot, Thromboelastography, Cardiac Surgery, Liver Transplant, Platelet Function Analyzer

For more information, please visit: www.lifediagnostica.com

IACTA 2012, Sonoclot, Thromboelastography, Liver Transplant India, Cardiac Surgery, Cath Lab, www.lifediagnostica.com, Life Diagnostica

ISA 2012, Sonoclot, Thromboelastography, Liver Transplant India,Cardiac Surgery, Cath Lab, www.lifediagnostica.com, Life Diagnostica

Sonoclot coagulation analysis: new bedside monitoring for determination of the appropriate heparin dose during haemodialysis

Sonoclot coagulation analysis: new bedside monitoring for determination of the appropriate heparin dose during haemodialysis <![if !supportLists]> 1.         <![endif]>   <![if !supportLists]> 2.         <![endif]> Masato Furuhashi ,   Nobuyuki Ura ,   Koichi Hasegawa ,   Hideaki Yoshida , Kazufumi Tsuchihashi ,   Tetsuji Miura   and   Kazuaki Shimamoto <![if !supportLists]> 1.         <![endif]> Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan Abstract Background. Thrombotic and haemorrhagic complications affect cardiovascular morbidity and mortality in haemodialysis patients. We investigated whether a new bedside Sonoclot analysis is useful for determining an appropriate heparin dose during haemodialysis.  Methods. Twenty‐two ...

Update on Liver Transplant Anaesthesia, Sonoclot, Life Diagnostica

Sonoclot, Thromboelastography, Liver Transplant India, Cardiac Surgery For more information, please visit:    www.lifediagnostica.com

Eric Abidal training in Pyrenees after liver transplant

Barcelona defender Eric Abidal is training in the Pyrenees mountains following a liver transplant in April, the   La Liga   club said on Tuesday. The 33-year-old France international is working with club physio Emili Ricart on a regime that includes aerobic work, mountain walks and ball work on a training pitch, Barca said in a statement on their website (www.fcbarcelona.com). Abidal had an operation to remove a tumour from his liver in March 2011 before making a triumphant return two months later to lift the Champions League trophy after Barca's victory over   Manchester United   in the final in London. Doctors later decided the former Monaco and Olympique Lyon player needed a transplant and he said in August he was targeting a return before December. For more information on Sonoclot, Thromboelastography in Liver Transplant, please visit: www.lifediagnostica.com

Disseminated Intravascular Coagulation (DIC) | Sonoclot Analyzer India | Thromboelastography | TEG

Disseminated Intravascular Coagulation (DIC) The DIC process can be divided into three stages: • Hypercoagulable (Stage I) • Secondary fibrinolytic (Stage II) • Hypocoagulable (Stage III) Hypercoagulable (Stage I) DIC is commonly initiated through release of tissue factor (TF) and FVIIa activation of the extrinsic pathway, resulting in a deposition of thrombin in the microcirculation system. TF is normally contained within the cellular membrane and encrypted. However, traumatic tissue injury, required major resuscitation, or major surgery, exposes TF to the bloodstream. TF expression can also occur when monocytes are activated by sepsis, endotoxin, the presence of cancerous cells, or in pregnancy when amniotic fluid penetrates the maternal blood stream. In summary, the release of TF, together with FVIIa, initiates the extrinsic coagulation cascade and, if it is not anticoagulated accordingly, with heparin low molecular weight heparin (LMWH), or activated protein C ...